investors
Nasdaq: Damien Perriman interview on NCT
CCO at eXoZymes, Damien Perriman, interviewed at Nasdaq around our NCT project: "We’ve shown that...
investors
Interview: Cayman Chemical validates eXoZymes' technology...
Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter...
investors
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)
One of the biggest challenges of conventional technologies is the long timelines to advance...
interview
The Catalyst Podcast: Interview with CEO Michael Heltzen
The Catalyst Podcast by Igor Rafalovich is available here:...
interview
Inside Biotech podcast (E34): Michael Heltzen interview
Serial entrepreneur Michael Heltzen, CEO of eXoZymes, reveals how his NASDAQ-listed company is...